• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Infectious Disease

Chronic Wasting Disease Spreads Silently in Symptom-Free Animals, Raising Questions About Long-Term Human Risk

byDeepti Shroff
September 4, 2026
in Infectious Disease
Reading Time: 2 mins read
HOSPITAL score predicts risk of 30-day potentially avoidable readmission to hospital
Share on FacebookShare on TwitterShare on LinkedIn

1. A University of Calgary study published in Science Advances this month found that chronic wasting disease can spread silently in animals with no clinical symptoms, and demonstrated limited but detectable cross-species prion transmission in nonhuman primate models.

2. There are no confirmed human cases, but the expanding geographic footprint of the disease in wild cervid populations means the cumulative exposure risk is rising, and public health experts say this study reinforces the case for sustained surveillance.

Chronic wasting disease gets less public health attention than it probably deserves. It affects deer, elk, moose, and caribou rather than livestock or people, no human case has ever been confirmed, and the prion field does not generate the same media urgency as influenza or emerging viruses. A paper published in June 2026 in Science Advances by University of Calgary researchers and international collaborators adds findings that warrant closer attention. The first is that animals with no visible clinical symptoms can shed infectious prions, meaning surveillance programs that look for sick animals are systematically undercounting how widely the disease has spread in wild populations. The second is that in experimental settings, cervid prions showed limited but real transmission to nonhuman primates, and displayed capacity for adaptation under laboratory conditions. The researchers are careful not to overstate this. As they noted in the paper, their findings do not indicate an immediate risk to humans. But the situation is more nuanced than previously understood. There has never been a confirmed human case, and the species barrier between cervids and humans currently appears strong. What the Center for Infectious Disease Research and Policy at the University of Minnesota has consistently pointed out, however, is that prion diseases are uniformly fatal with no treatment options, that species barriers can change as prions evolve in large infected reservoirs, and that the comparison to BSE is not a rhetorical device but a cautionary historical precedent. The more the disease spreads in animals, the more human exposure opportunities accumulate, and exposure risk scales with prevalence. For clinicians, none of this changes the guidance for patients who hunt in affected states, but it does make it worth giving that guidance proactively: have harvested animals tested where state programs exist, avoid consuming meat from animals that appear sick, use gloves when field dressing carcasses, and avoid contact with the brain, spinal cord, eyes, and lymph nodes where prion concentrations are highest. The concern here is not about an imminent threat. It is about what happens when a fatal untreatable disease keeps expanding in a large wild animal population over the next decade, and whether the public health infrastructure to detect and respond to a species jump will exist when it matters.

Image: PD

©2026 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

No Content Available
Tags: Asymptomatic SheddingCIDRAPCWDHuman RiskHunting ExposurePrion DiseaseSpecies BarrierZoonotic Risk
Previous Post

Septoplasty is more costly but more effective than medical management for deviated septum

Next Post

Infection risk with infliximab (Remicade) and adalimumab (Humira) is similar in pediatric inflammatory bowel disease

RelatedReports

No Content Available
Next Post
Features predicting treatment failure in acute otitis media

Infection risk with infliximab (Remicade) and adalimumab (Humira) is similar in pediatric inflammatory bowel disease

Lower vulvar cancer-related mortality in African Americans

Cryoanalgesia increases neuropathic pain after minimally invasive thoracic surgery

Epidural corticosteroid injections provide only short-term radiculopathy pain relief

Spinal instability may be the primary cause of pain in sacral metastases as opposed to neurologic compromise

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Children with intellectual and developmental disabilities have increased risks of depression and anxiety
  • Gabapentin (Neurontin) prescription for chronic low back pain in adults is associated with a higher risk of dementia
  • The rate of urethrocutaneous fistula formation may be similar between caudal and penile blocks
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.